TY - JOUR
T1 - Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?
AU - Ernst, Erika J.
AU - Diekema, Daniel J.
AU - BootsMiller, Bonnie J.
AU - Vaughn, Thomas
AU - Yankey, Jon W.
AU - Flach, Stephen D.
AU - Ward, Marcia M.
AU - Franciscus, Carrie L.J.
AU - Acosta, Elise
AU - Pfaller, Michael A.
AU - Doebbeling, Bradley N.
N1 - Funding Information:
This study was supported by a Merit Review Grant from Medical Research, Department of Veterans Affairs, titled Epidemiology and Control of Antimicrobial Resistance in Hospitals. The authors greatly appreciate the data shared for the study by laboratory directors at each participating hospital, as well as letters of support and advice from William Martone, M.D., Senior Executive Director, National Foundation for Infectious Diseases; Dale Gerding, M.D., President, Society for Healthcare Epidemiology of America; and Elaine Larson, R.N., Ph.D., Professor of Pharmaceutical and Therapeutic Research, Columbia University School of Nursing.
PY - 2004/6
Y1 - 2004/6
N2 - The National Committee for Clinical Laboratory Standards recently published guidelines for analysis and presentation of cumulative antimicrobial susceptibility test data (antibiograms). We sought to determine how well US hospitals already adhere to standards for antibiogram compilation, and to examine the relationship between hospital characteristics and guideline adherence. We surveyed laboratory directors at 670 hospitals and examined 3 guideline criteria: compilation of an antibiogram, annual updating, and distribution to infection control staff and medical staff yearly; 494 surveys were returned (74%). Almost all of the hospitals surveyed publish an antibiogram (95%, n = 481); however, only 60% (n = 296) met all three criteria. Hospital laboratories meeting criteria were more likely to serve as referral laboratories (OR = 1.82; 95% CI = 1.26-2.63), perform susceptibility testing on site (OR = 4.47; 95% CI = 1.84-10.84), use confirmatory tests to detect extended-spectrum β-lactamases (OR = 1.8; 95% CI = 1.2-2.6), and have more laboratory personnel per bed (3.0 vs. 2.0 FTEs/bed, p = 0.0031). Adherence to guidelines for preparation and dissemination of antibiograms could be improved. Institutional commitment to high quality, on-site microbiology laboratory services will improve adherence to these guidelines.
AB - The National Committee for Clinical Laboratory Standards recently published guidelines for analysis and presentation of cumulative antimicrobial susceptibility test data (antibiograms). We sought to determine how well US hospitals already adhere to standards for antibiogram compilation, and to examine the relationship between hospital characteristics and guideline adherence. We surveyed laboratory directors at 670 hospitals and examined 3 guideline criteria: compilation of an antibiogram, annual updating, and distribution to infection control staff and medical staff yearly; 494 surveys were returned (74%). Almost all of the hospitals surveyed publish an antibiogram (95%, n = 481); however, only 60% (n = 296) met all three criteria. Hospital laboratories meeting criteria were more likely to serve as referral laboratories (OR = 1.82; 95% CI = 1.26-2.63), perform susceptibility testing on site (OR = 4.47; 95% CI = 1.84-10.84), use confirmatory tests to detect extended-spectrum β-lactamases (OR = 1.8; 95% CI = 1.2-2.6), and have more laboratory personnel per bed (3.0 vs. 2.0 FTEs/bed, p = 0.0031). Adherence to guidelines for preparation and dissemination of antibiograms could be improved. Institutional commitment to high quality, on-site microbiology laboratory services will improve adherence to these guidelines.
UR - http://www.scopus.com/inward/record.url?scp=2942562154&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2942562154&partnerID=8YFLogxK
U2 - 10.1016/j.diagmicrobio.2004.03.007
DO - 10.1016/j.diagmicrobio.2004.03.007
M3 - Article
C2 - 15183864
AN - SCOPUS:2942562154
SN - 0732-8893
VL - 49
SP - 141
EP - 145
JO - Diagnostic Microbiology and Infectious Disease
JF - Diagnostic Microbiology and Infectious Disease
IS - 2
ER -